Carbiotix Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Carbiotix şirketinin toplam hissedar öz sermayesi SEK26.1M ve toplam borcu SEK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK27.7M ve SEK1.6M dir.

Anahtar bilgiler

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranı	n/a
Nakit	SEK 5.04m
Eşitlik	SEK 26.09m
Toplam yükümlülükler	SEK 1.61m
Toplam varlıklar	SEK 27.70m

Son finansal sağlık güncellemeleri

Companies Like Carbiotix (NGM:CRBX) Are In A Position To Invest In Growth

Aug 28

Is Carbiotix (NGM:CRBX) In A Good Position To Invest In Growth?

Feb 04

Recent updates

Companies Like Carbiotix (NGM:CRBX) Are In A Position To Invest In Growth

Aug 28

Is Carbiotix (NGM:CRBX) In A Good Position To Invest In Growth?

Feb 04

Kristofer Cook Is The CEO & Director of Carbiotix AB (publ) (NGM:CRBX) And They Just Picked Up 1.8% More Shares

Dec 13

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CRBX 'nin kısa vadeli varlıkları ( SEK6.8M ) kısa vadeli yükümlülüklerini ( SEK1.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: CRBX un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CRBX borçsuzdur.

Borcun Azaltılması: CRBX şirketinin 5 yıl önce borç/öz sermaye oranı 3.5% iken borcu yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: CRBX şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: CRBX un, serbest nakit akışı her yıl % 18.6 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Carbiotix Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Companies Like Carbiotix (NGM:CRBX) Are In A Position To Invest In Growth

Is Carbiotix (NGM:CRBX) In A Good Position To Invest In Growth?

Recent updates

Third quarter 2024 earnings released

Carbiotix AB (publ) to Report Q3, 2024 Results on Nov 05, 2024

Carbiotix AB (Publ) Initiates Eight New NutraCycle Pre- Study Projects

Second quarter 2024 earnings released

Carbiotix AB (publ) to Report Q4, 2024 Results on Aug 06, 2024

Carbiotix AB (Publ) Provides Update of Staff Re-Organisation

Carbiotix AB (publ) to Report Q1, 2024 Results on May 07, 2024

Carbiotix Commences NutraCycle Pilot Study with Leading US Food & Beverage Producer

Carbiotix AB (publ), Annual General Meeting, Apr 26, 2024

Carbiotix (publ) Commences Nutracycle Pre- Study with Leading US Food & Beverage Producer

Carbiotix Launches NutraCycle - a New Upcycling Service for Food & Beverage Producers

New major risk - Shareholder dilution

Carbiotix AB (publ) has completed a Composite Units Offering in the amount of SEK 14.222561 million.

Carbiotix AB (publ) Completes CarbiAXOS Production Upgrade

Carbiotix AB (publ) to Report Fiscal Year 2023 Results on Feb 16, 2024

New major risk - Shareholder dilution

Carbiotix AB (publ) Achieves Regulatory Approval for CarbiAXOS Cosmetic Ingredient

Carbiotix (Publ) Announces Promising Preliminary Results from the 4-Month Randomised Controlled Carbiaxos Intervention Study Involving Type-2 Diabetes Patients on Metformin

Chairman & CBDO recently bought kr87k worth of stock

Carbiotix AB (publ) to Report Nine Months, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings released

Carbiotix AB (publ) to Report Q2, 2023 Results on Aug 08, 2023

Carbiotix AB (publ) to Report Q2, 2023 Results on Aug 08, 2023

New minor risk - Shareholder dilution

Full year 2022 earnings released: kr0.85 loss per share (vs kr0.85 loss in FY 2021)

Carbiotix Announces Board Changes

Carbiotix AB (publ) to Report Fiscal Year 2023 Results on Feb 17, 2023

No independent directors

Carbiotix AB (publ) to Report Q3, 2022 Results on Nov 08, 2022

Carbiotix AB (publ) to Report Q2, 2022 Results on Aug 09, 2022

No independent directors

Carbiotix AB (Publ) Hires Richard A. Rosenbloom as Its New Chief Medical Officer

Carbiotix AB (publ) Completes the CarbiAXOS Production Line and Prepares for Start-Up

Carbiotix AB (publ) to Report Q1, 2022 Results on May 10, 2022

CEO & Director recently bought kr114k worth of stock

Carbiotix AB (publ) Announces the US Patent for the Production of CarbiAXOS Has Been Allowed for Issuance by the US Patent Office

Full year 2021 earnings released

CEO & Director recently bought kr218k worth of stock

Carbiotix AB (Publ) Announces Management Changes

CEO & Director recently bought kr144k worth of stock

CEO & Director recently bought kr395k worth of stock

Companies Like Carbiotix (NGM:CRBX) Are In A Position To Invest In Growth

CEO & Director recently bought kr127k worth of stock

Carbiotix AB (publ) Announces Evaluation of New Production Enzyme Yields Positive Results

CEO & Director recently bought kr259k worth of stock

Is Carbiotix (NGM:CRBX) In A Good Position To Invest In Growth?

New 90-day high: kr16.34

Kristofer Cook Is The CEO & Director of Carbiotix AB (publ) (NGM:CRBX) And They Just Picked Up 1.8% More Shares

CEO & Director recently bought kr181k worth of stock

New 90-day high: kr6.00

New 90-day low: kr4.01

First half earnings released

New 90-day high - kr4.92

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin